Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05371886

Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
20 Weeks – 45 Weeks
Healthy volunteers
Not accepted

Summary

This study aims to describe a dose-effect relationship of morphine alone and morphine and midazolam administered as continuous infusion in neonates hospitalized in Neonatal intensive care unit and undergoing mechanical ventilation, through PKPD modelling.

Detailed description

This study will include all neonates receiving a sedo-analgesia with continuous infusion of morphine alone or morphine and midazolam during mechanical ventilation in 3 French NICUs. Comfort and pain will be assessed by COMFORTneo pain scores and Newborn Infant Parasympathetic Evaluation Index. Morphine, midazolam and their metabolites' concentrations will be determined on samples taken during a planned blood test. Through PKPD modelling, the dose-concentration-effect relationships will be found and interindividual variability of these drugs in neonates and simulate doses needed to achieve comfort in neonates according to their individual characteristics (gestational age, post-natal age, weight etc.).

Conditions

Interventions

TypeNameDescription
OTHERDose-effect relationship of morphine +/- midazolam administrationDose-effect relationship of morphine +/- midazolam administration as continuous infusion in neonates undergoing mechanical ventilation through PKPD modelling

Timeline

Start date
2023-04-01
Primary completion
2023-07-01
Completion
2027-05-01
First posted
2022-05-12
Last updated
2025-11-17

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05371886. Inclusion in this directory is not an endorsement.